<DOC>
	<DOC>NCT00182104</DOC>
	<brief_summary>Compare heparin/warfarin to ASA for thromboembolic prophylaxis in the first two years following Fontan procedures.</brief_summary>
	<brief_title>International Multi Centre Randomized Clinical Trial Of Anticoagulation In Children Following Fontan Procedures</brief_title>
	<detailed_description />
	<mesh_term>Warfarin</mesh_term>
	<criteria>1. Patient is scheduled to have a Fontan or modified Fontan procedure 1. Requirement for longterm anticoagulation (e.g., prosthetic heart valve, active DVT) 2. Risk of significant bleeding or any other known medical contraindication to Heparin, Warfarin, or ASA. 3. Inability to supervise therapy due to social or geographical reasons. 4. Pregnancy or potential pregnancy during study period</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Fontan procedure</keyword>
	<keyword>Anticoagulation</keyword>
	<keyword>Thrombosis</keyword>
	<keyword>Thromboembolism</keyword>
	<keyword>Prevention</keyword>
</DOC>